SEC Comment Letter 0000000000-25-000884 to PSYENCE BIOMEDICAL LTD. (PBM)
PSYENCE BIOMEDICAL LTD.
Date: Jan. 28, 2025 · CIK: 0001985062 · Accession: 0000000000-25-000884
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284444
Letter
January 28, 2025 Neil Maresky Chief Executive Officer Psyence Biomedical Ltd. 121 Richmond Street West Penthouse Suite 1300 Toronto, Ontario M5H 2K1 Re:Psyence Biomedical Ltd. Registration Statement on Form F-1 Filed January 24, 2025 File No. 333-284444 Dear Neil Maresky: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Ari Edelman
Show Raw Text
January 28, 2025
Neil Maresky
Chief Executive Officer
Psyence Biomedical Ltd.
121 Richmond Street West
Penthouse Suite 1300
Toronto, Ontario M5H 2K1
Re:Psyence Biomedical Ltd.
Registration Statement on Form F-1
Filed January 24, 2025
File No. 333-284444
Dear Neil Maresky:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Ari Edelman